Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.61
+0.66 (4.73%)
At close: Nov 7, 2025, 4:00 PM EST
14.65
+0.04 (0.27%)
After-hours: Nov 7, 2025, 7:56 PM EST
Aurinia Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts that cover Aurinia Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $17.67, which forecasts a 20.94% increase in the stock price over the next year. The lowest target is $15 and the highest is $21.
Price Target: $17.67 (+20.94%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Aurinia Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 1 | 2 | 2 | 2 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $10 → $21 | Hold → Strong Buy | Upgrades | $10 → $21 | +43.74% | Nov 7, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $9 → $15 | Buy → Hold | Downgrades | $9 → $15 | +2.67% | Nov 5, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | -38.40% | Aug 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +16.36% | Jul 30, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $10 | Buy | Reiterates | $10 | -31.55% | Sep 16, 2024 |
Financial Forecast
Revenue This Year
275.89M
from 235.13M
Increased by 17.33%
Revenue Next Year
315.38M
from 275.89M
Increased by 14.31%
EPS This Year
0.66
from 0.04
Increased by 1,553.24%
EPS Next Year
0.78
from 0.66
Increased by 17.48%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 290.0M | 374.8M | |||
| Avg | 275.9M | 315.4M | |||
| Low | 259.7M | 278.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.3% | 35.8% | |||
| Avg | 17.3% | 14.3% | |||
| Low | 10.4% | 1.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.85 | 1.28 | |||
| Avg | 0.66 | 0.78 | |||
| Low | 0.49 | 0.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2,026.3% | 93.7% | |||
| Avg | 1,553.2% | 17.5% | |||
| Low | 1,125.0% | -15.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.